Technical Resources

Recombinant cascade reagents (rCR) are recombinant protein-based detection systems designed for endotoxin assays, replacing traditional LAL reagents. rCR consists of key recombinant proteins(recombinant Factor C, recombinant Factor B, and recombinant pro-clothing enzyme) from the Limulus coagulation cascade. These proteins are expressed via genetic engineering to replicate the endotoxin-recognition and signal-amplification function of natural LAL.

The key characteristics of BETMAT rCR are:

➢ High specificity: There is no factor G in the rCR reagent, thus it is an endotoxin-specific reagent that eliminates the risk of false positives from (1-->3) ß-D-Glucan.

➢ Stability & consistency: Gene recombinant technology enables BETMAT to produce rCR reagents which avoids batch-to-batch variation of natural LAL.

➢ Ethical & sustainable: Eliminates the need for using horseshoe crab blood, reducing ecological impact.

➢ High Sensitive: rCR reagent mimics signal amplification cascade in the factor C pathway, enabling detection of endotoxin using kinetic chromogenic method with a high sensitivity.

BETMAT rCR is a kinetic chromogenic assay similar to nature LAL kinetic chromogenic assay. The assay method is fully compatible with existing incubating microplate readers, software, and endotoxin-free accessories for kinetic chromogenic assay. There is no need to inquire about new endotoxin assay instruments for BETMAT rCR assay. This allows for easier integration BETMAT rCR assay by reducing the learning curve, creating cost efficiencies.

Recombinant factor C (rFC) and recombinant cascade reagents (rCR) are both used for endotoxin assays, but they differ in terms of composition, reaction principles, detection methods, and performance characteristics. The specific differences are as follows:

➢ Composition: rFC contains only a single enzyme, recombinant Factor C, the first enzyme in amoebocytes of horseshoe crab serine protease catalytic cascade activated by endotoxin. In contrast, rCR consists of three enzymes, recombinant Factor C, recombinant Factor B, and recombinant proclotting enzyme, which reconstructs a complete reaction cascade, similar to the composition of natural LAL reagent.

➢ Reaction Principle: When using rFC for detection, endotoxin activates the recombinant Factor C, and the activated Factor C cleaves the fluorescent substrate to produce a fluorescent signal, which is a relatively simple single - step reaction. rCR simulates the enzyme - linked reaction of natural LAL reagent. Endotoxin first activates recombinant Factor C, then sequentially activates recombinant Factor B, and finally converts recombinant proclotting enzyme into clotting enzyme, forming a three - step reaction chain.

➢ Detection Method: rFC usually requires a fluorescence microplate reader for quantitative determination of the fluorescent signal by end point assay. rCR, on the other hand, can be detected by a kinetic absorbance microplate reader, and it monitors the signal through color change, which is the same as the detection method of traditional kinetic chromogenic LAL reagent.

➢ Instrument Requirements: rFC detection requires the use of fluorescence - based instruments. rCR can use the same type of instrument as the traditional LAL reagent, and there is no need to change the detection equipment, which is more convenient for laboratories that originally used traditional methods to transition.

BETMAT designed our rCR reagent using the same testing methodology of nature kinetic chromogenic LAL assay. Users will prepare the rCR assay the same way as the traditional chromogenic LAL assay. The rCR assay uses 100 µl of sample, negative controls, and standards, as well as 100 µl of rCR reagent in each assay well.

Recombinant cascade reagents are increasingly recognized globally, with some pharmacopoeias having included them as official methods, while others are still in the process of improvement and harmonization. The specific regulatory status is as follows:

➢ United States: The United States Pharmacopeia (USP) has included recombinant Factor C (rFC) and recombinant cascade reagent (rCR) in USP 〈86 〉 Bacterial Endotoxins Test Using Recombinant Reagents in May 2025. According to the regulations, users are required to verify the applicability of recombinant reagents to specific products.

➢ Europe: The European Pharmacopoeia (EP) has included the recombinant Factor C method in General Chapter 2.6.32 Test for Bacterial Endotoxins Using Recombinant Factor C. It stipulates that water for injection and purified water can be directly detected by this method, and complex matrix samples need to be used after verification. However, currently, EP 2.6.32 only includes the recombinant Factor C method, and has not yet included recombinant cascade reagents.

➢ Japan: The Japanese Pharmacopoeia lists recombinant protein reagents, includes rFC and rCR as a supplementary method for endotoxin testing through the guideline < G4 - 4 - 180 >Bacterial Endotoxins Test and Alternative Methods using Recombinant Protein-reagents for Endotoxin Assay, which describes the procedures and considerations for using recombinant protein reagents for endotoxin testing.

Yes, according USP charpter 〈86 〉 Bacterial Endotoxins Test Using Recombinant Reagents, the users will have to validate recombinant cascade reagent assay method before implementing this new assay. BETMAT provides primary validation package for the users to verify that the recombinant cascade reagent is appropriate for use in testing specific products or materials.

The LAL (Limulus Amebocyte Lysate) test is a widely used biological assay to detect the presence of endotoxins (toxic substances found in the outer membrane of Gram-negative bacteria, e.g., E. coli , *Salmonella*). It leverages a unique biological reaction from the blood cells (amebocytes) of the horseshoe crab (Limulus polyphemus or related species).

Here’s a brief breakdown of its working principle:

1. Sample Preparation

The test sample (e.g., pharmaceuticals, medical devices, injectables, or environmental water and etc.) is first processed to eliminate interfering substances (e.g., proteins, detergents) that might disrupt the reaction. It is then mixed with LAL reagent—an extract of lysed (broken-open) amebocytes from horseshoe crabs.

2. Endotoxin-LAL Reaction

Endotoxins bind to specific proteins in the LAL reagent, triggering a cascade of enzymatic reactions. This cascade activates a proenzyme in LAL, converting it into an active enzyme.

3. Detection of the Reaction Product

The active enzyme catalyzes the cleavage of a synthetic substrate (added to the mixture) or the formation of a clot (in traditional LAL tests).

- In gel-clot LAL (the most widely applied format), a visible gel forms if endotoxins are present (the enzyme crosslinks LAL proteins into a solid gel).

- In chromogenic LAL, the cleaved substrate releases a colored compound; the intensity of the color is measured and correlated to endotoxin concentration.

- In turbidimetric LAL, the reaction causes the mixture to become cloudy (turbid); turbidity is measured to quantify endotoxins.

4. Result Interpretation

A positive result (gel formation, color change, or turbidity) indicates endotoxin contamination above a predefined threshold. Negative results confirm the sample is endotoxin-free (or below safe limits, critical for medical products to avoid fever, sepsis, or organ damage in patients).

The LAL (Limulus Amebocyte Lysate) reagent is a widely used biological assay to detect the presence and quantify endotoxins—harmful substances released by the cell walls of gram-negative bacteria (e.g., E. coli, Salmonella).

It leverages a unique property of amebocyte lysate (a fluid extracted from the blood cells of horseshoe crabs, Limulus polyphemus): when endotoxins interact with this lysate, a clotting reaction (gel formation) or color change occurs.

Common applications include testing pharmaceuticals (e.g., injectables, vaccines), medical devices (e.g., catheters), and water for injection — ensuring these products are free of endotoxins, which can cause severe reactions (e.g., fever, sepsis) in humans.

The LAL (Limulus Amebocyte Lysate) assay is a critical method to detect and quantify endotoxin (a toxic component of the outer membrane of Gram-negative bacteria), which can cause severe adverse reactions (e.g., fever, sepsis, organ failure) if present in medical products or environments. It is primarily performed in the following scenarios, with brief descriptions:

1. For Pharmaceutical & Biopharmaceutical Products

It is mandatorily performed for most injectable drugs, vaccines, biologics (e.g., monoclonal antibodies), and parenteral formulations (products administered via IV, intramuscular, or subcutaneous routes). Endotoxin contamination in these products poses direct risks to patients, so the LAL test verifies compliance with regulatory endotoxin limits (e.g., USP, EP, JP standards) before manufacturing release.

2. For Medical Devices

It is required for devices that contact the bloodstream, cerebrospinal fluid (CSF), or sterile tissues (e.g., intravenous catheters, hemodialysis filters, surgical implants, CSF shunts). These devices can harbor endotoxin from manufacturing or sterilization gaps; the test ensures they are endotoxin-free to prevent infections or inflammatory responses.

3. For Raw Materials & Manufacturing Environments

Raw materials: Tested for components used in pharmaceuticals/medical devices (e.g., water for injection, excipients, cell culture media) to prevent endotoxin from entering the final product via contaminated inputs.

Environmental monitoring: Performed on surfaces, air, or process water in cleanrooms (e.g., pharmaceutical manufacturing facilities) to assess microbial control and avoid cross-contamination.

4. For Research & Specialized Applications

In biological research, it validates endotoxin levels in cell culture reagents (e.g., sera, buffers) to avoid interfering with experimental results (endotoxin can alter cell behavior).

In veterinary medicine, it tests animal vaccines or injectable treatments to ensure safety for livestock/pets.

Recombinant Cascade Reagent (rCR), a key component in the recombinant Limulus Amebocyte Lysate (rLAL) assay, and naturally occurring LAL (derived from the blood cells of horseshoe crabs) are both widely used for detecting bacterial endotoxins—a critical quality control step in pharmaceuticals, medical devices, and biologics. Their "goodness" depends on core performance metrics, practicality, and sustainability, and they are generally comparable in key areas while each having distinct strengths:

1. Core Performance: Generally Equivalent for Endotoxin Detection
In terms of the primary function—sensitivity, specificity, and accuracy—rCR performs on par with naturally occurring LAL for most routine endotoxin testing needs:
● Sensitivity: Both can detect endotoxins at extremely low levels (typically down to 0.005–0.01 EU/mL, depending on the assay format), meeting global regulatory requirements (e.g., USP, EP, JP).
● Specificity: rCR targets the same endotoxin (lipopolysaccharide, LPS) moiety as natural LAL (via the Limulus coagulation cascade’s first step, C Factor activation), so it rarely produces false positives/negatives for LPS—matching natural LAL’s specificity for most samples.
● Accuracy & Precision: When validated per regulatory standards, rCR-based assays (e.g., rLAL kinetic chromogenic assays) show similar reproducibility to natural LAL, with consistent results across laboratories and sample types (e.g., injectable drugs, medical devices).

2. Practical Advantages of rCR Over Natural LAL
While natural LAL has a long history of reliability, rCR addresses key limitations of the natural source:
● Sustainability: Natural LAL relies on harvesting horseshoe crabs (a threatened/near-threatened species in some regions), which involves capturing, bleeding, and releasing the animals (with ~10–30% mortality). rCR is produced via microbial fermentation (e.g., E. coli or yeast), eliminating dependence on wild horseshoe crab populations—aligning with global conservation goals.
● Consistency & Supply Stability: Natural LAL batches can vary in potency due to differences in horseshoe crab age, habitat, or processing. rCR is a highly purified, recombinant protein, so batch-to-batch variation is minimal, ensuring more consistent assay performance. It also avoids supply disruptions from horseshoe crab population declines or environmental factors (e.g., climate change, pollution).
● Safety & Contamination Risk: Natural LAL may contain trace contaminants from horseshoe crab blood (e.g., other proteins, inhibitors) that can interfere with certain samples (e.g., complex biologics). rCR, being a single, recombinant protein, has lower interference risk, simplifying validation for challenging samples.

3. Niche Scenarios Where Natural LAL May Still Be Preferred
For most standard applications, rCR is interchangeable with natural LAL, but natural LAL retains minor advantages in very specific cases:
● Detection of Non-LPS Pyrogens: Natural LAL can indirectly detect some non-endotoxin pyrogens (e.g., certain bacterial proteins) in rare cases, though this is not its primary function. rCR is strictly LPS-specific—though this is rarely a limitation, as regulatory testing focuses on endotoxins (the most common pyrogen in pharmaceuticals).
● Legacy Validation: Some long-established manufacturers may have decades of validation data for natural LAL and prefer to maintain continuity, rather than re-validating with rCR (though regulatory bodies like the FDA and USP now explicitly accept rCR as an alternative).
Conclusion
For most practical purposes, rCR is as "good as" naturally occurring LAL—matching its performance in sensitivity, specificity, and accuracy for endotoxin detection. Moreover, rCR offers critical advantages in sustainability, supply stability, and consistency, making it an increasingly preferred alternative. Natural LAL remains relevant only in niche scenarios or for legacy workflows, but rCR is now widely recognized as a comparable (and often superior) solution for modern endotoxin testing.

1. What is LAL Reagent Water ?
LAL Reagent Water (LRW) is a high-purity, specially treated water designed exclusively for use in the Limulus Amebocyte Lysate (LAL) Test—the gold standard method for detecting and quantifying bacterial endotoxins (a toxic component of the outer membrane of Gram-negative bacteria, e.g., E. coli).

Its primary role is to serve as a diluent, blank, or reagent solvent throughout the LAL Test workflow. For example:
● Diluting test samples (e.g., pharmaceuticals, medical devices, or parenteral solutions) to a concentration suitable for endotoxin detection.
● Preparing LAL reagent working solutions (e.g., reconstituting lyophilized LAL powder).
● Serving as a negative control (blank) to validate the test’s accuracy by confirming no external endotoxins are introduced.

To ensure it does not interfere with the LAL Test, LRW must meet strict purity criteria beyond general purified water (e.g., USP Purified Water or WFI). Key requirements include:
● Endotoxin-free: No detectable bacterial endotoxins (critical for test validity).
● Low mineral content: Minimal ions (e.g., calcium, magnesium) that could inhibit the LAL-endotoxin reaction.
● Neutral pH: Typically 6.0–8.0, as extreme pH levels can denature LAL proteins and disrupt the test.
● No interfering substances: Absence of compounds that might activate (false positive) or inhibit (false negative) the LAL coagulation cascade (e.g., detergents, chelating agents, or residual chemicals from water treatment).

2. Why Must LAL Reagent Water Meet Endotoxin-Free Standards?
The LAL Test relies on a highly specific and sensitive biological reaction between LAL (a protein extract from horseshoe crab blood cells) and bacterial endotoxins. Endotoxins trigger a coagulation-like cascade in LAL, resulting in a gel formation (for qualitative tests) or a color change (for quantitative tests)—the intensity of which correlates with endotoxin concentration.

If LRW is not endotoxin-free, it will introduce extraneous endotoxins into the test system, leading to two critical problems that render the LAL Test useless:
(1) Prevents False Positive Results
A false positive occurs when the test incorrectly indicates the presence of endotoxins in a sample that is actually endotoxin-free.
● Example: If LRW contains trace endotoxins and is used to dilute a sterile pharmaceutical (e.g., a vaccine), the LAL Test will detect the endotoxins from the water—not the vaccine. This could falsely label a safe product as contaminated, leading to unnecessary product recalls, wasted resources, or delayed patient access to critical treatments.
(2) Ensures Accurate Quantification (for Quantitative LAL Tests)
In quantitative LAL Tests (e.g., kinetic chromogenic or turbidimetric methods), the goal is to measure the exact concentration of endotoxins in the sample.
● Endotoxin contamination in LRW adds an "unaccounted background" of endotoxins. This background cannot be distinguished from endotoxins in the test sample, making it impossible to calculate the true endotoxin level of the sample. For example, if LRW has 0.05 EU/mL (Endotoxin Units per mL) of endotoxins, and the test sample’s measured value is 0.1 EU/mL, the actual sample endotoxin level (0.05 EU/mL) would be inaccurately overestimated.
(3) Validates Test Integrity
Regulatory bodies (e.g., FDA, EMA, USP, EP) mandate that the LAL Test must be validated to ensure it is reliable and free from interference. A critical part of validation is confirming that LRW itself does not contribute endotoxins.
● If LRW is not endotoxin-free, the test’s "negative control" (which uses LRW alone) will show a positive reaction—immediately invalidating the entire test batch. This means all samples tested with that LRW cannot be trusted, requiring re-testing and causing delays.

In summary, LAL Reagent Water is a specialized high-purity water for the LAL Test. Its endotoxin-free requirement is non-negotiable: it prevents false positives, ensures accurate endotoxin quantification, and validates the test’s integrity—all critical for complying with regulatory standards and ensuring the safety of pharmaceuticals, medical devices, and other products.

Bacterial endotoxin testing (BET) primarily relies on three main approaches, each leveraging distinct mechanisms to detect endotoxins (lipopolysaccharides from Gram-negative bacteria):

1. Gel-Clot Method (Limulus Amebocyte Lysate, LAL): The traditional and widely used method. It uses a lysate from horseshoe crab (Limulus polyphemus) amebocytes—endotoxin triggers a coagulation cascade in the lysate, forming a visible gel if endotoxins exceed a threshold. It is simple, cost-effective, and suitable for qualitative/ semi-quantitative testing.

2. Chromogenic Method (LAL-based): Also uses LAL but incorporates a chromogenic substrate. Endotoxin activates enzymes in LAL, which cleave the substrate to release a colored product. The intensity of the color is measured spectrophotometrically and correlates with endotoxin concentration, enabling quantitative results.

3. Turbidimetric Method (LAL-based): Another LAL-dependent quantitative approach. Endotoxin-induced coagulation of LAL increases the solution’s turbidity (cloudiness). Turbidity is measured over time (kinetic) or at a fixed point (endpoint) to calculate endotoxin levels, ideal for high-throughput testing.

A newer, animal-free alternative is the Recombinant Factor C (rFC) Assay: It uses a recombinant version of the first enzyme in the LAL cascade (Factor C), reducing reliance on horseshoe crabs. Endotoxin activates rFC, which triggers a signal (e.g., chromogenic or fluorescent) for quantitative detection, aligning with animal welfare initiatives.

In bacterial endotoxin testing, the gel-clot method is a qualitative detection method based on the specific reaction between limulus amebocyte lysate (LAL) and endotoxins. LAL, a coagulation protein component extracted from horseshoe crab blood, undergoes an enzyme-catalyzed coagulation reaction to form a gel when it comes into contact with bacterial endotoxins in the test sample. If the gel formed after the reaction is firm and does not flow when inverted 180 degree, it indicates that the endotoxin content in the sample may exceed the set limit (or endotoxins are detected); otherwise, no endotoxins are detected. This method is mainly used to determine whether a sample meets the endotoxin control standards.

In bacterial endotoxin testing (BET), the kinetic chromogenic method is a quantitative technique that detects/quantifies endotoxins by measuring the rate of color development over time, rather than a single endpoint color.

It relies on the Limulus Amebocyte Lysate (LAL) reaction: endotoxins activate enzymes in LAL, which then cleave a chromogenic substrate to release a colored product. By continuously monitoring the speed of color formation (kinetics) and comparing it to a standard curve of known endotoxin concentrations, the exact amount of endotoxin in the test sample is calculated. It offers high sensitivity and is widely used for samples requiring precise endotoxin quantification.

In bacterial endotoxin testing (BET), the kinetic turbidimetric method is a quantitative technique based on the Limulus Amebocyte Lysate (LAL) test principle.

It detects/quantifies bacterial endotoxins by measuring the rate of turbidity (cloudiness) change in the LAL-endotoxin reaction mixture over time. Endotoxins trigger a coagulation cascade in LAL, forming insoluble clots that increase turbidity. The method correlates the speed of turbidity development (e.g., time to reach a preset turbidity threshold) with the endotoxin concentration—higher endotoxin levels lead to faster turbidity formation. It enables precise quantification of endotoxin content in samples (e.g., pharmaceuticals, medical devices) and offers advantages like continuous monitoring and wide linearity.

BETMAT rCR is an animal-derived, endotoxin-free test reagent that mimics the natural LAL (Limulus Amebocyte Lysate) reaction, thereby contributing to the sustainable development of the industry.

Limulus Amebocyte Lysate (LAL) test as the normal solution, we also provide BETMAT rCR—an optimized, animal-free kinetic chromogenic recombinant cascade reagent (rCR). Specifically engineered to mimic the natural LAL reaction, BETMAT’s formulation and composition are carefully designed to include three essential biological proteins: recombinant Factor C, recombinant Factor B, and recombinant proclotting enzyme. Additionally, it contains key components at precisely calibrated concentrations to ensure reliable performance.

While the current practices for sourcing and using horseshoe crabs are conducted responsibly, there is still considerable room for innovation when it comes to developing alternative testing methods. The emergence of recombinant cascade reagents (rCR) introduces a transformative strategy: by leveraging biotechnology, these reagents can replicate the natural ability of horseshoe crabs to detect endotoxins. This transition is in line with the industry’s wider sustainability objectives.

Endotoxin testing is a method to detect or quantify endotoxins (mainly lipopolysaccharides from the outer membrane of Gram-negative bacteria) in pharmaceuticals, medical devices, biological products, or environmental samples. Its core purpose is to ensure these products are safe, as endotoxins can trigger harmful reactions like fever, shock, or organ damage in the human body when entering the bloodstream. The common methods include the Limulus Amebocyte Lysate (LAL) test and the recombinant Factor C (rFC) test.

Endotoxin testing in the laboratory mainly relies on two core methods: the Limulus Amebocyte Lysate (LAL) test (traditional and widely used) and the recombinant Factor C (rFC) test (animal-free alternative). Below is their typical workflow:
1. Pre-test Preparation
Sample Handling: Prepare test samples (e.g., pharmaceuticals, medical device rinsates, biological products) by diluting them with endotoxin-free water (to avoid interference) and adjusting pH to 6.0–8.0 (optimal for reagent reaction).
Reagent & Material Preparation: Ensure all tools (pipette tips, test tubes, containers) are endotoxin-free (sterilized by depyrogenation, e.g., dry heat at 250°C for ≥30 minutes). Thaw LAL reagent (stored at 2–8°C) or reconstitute rFC reagent as per instructions.
Positive/Negative Controls: Prepare a standard endotoxin solution (e.g., Escherichia coli O113:H10 endotoxin) as a positive control, and endotoxin-free water as a negative control (to verify reagent validity).

2. Core Testing Procedures (by Method)
Method 1: Limulus Amebocyte Lysate (LAL) Test
LAL is a protein extract from horseshoe crab blood cells; it coagulates or produces a color reaction when exposed to endotoxins. It has three common formats:
Gel-Clot Method (Qualitative/ Semi-quantitative):
1. Mix equal volumes of LAL reagent and sample (e.g., 0.1 mL each) in a test tube.
2. Incubate at 37±1°C for 60±2 minutes (no shaking).
3. Invert the tube: If a solid gel forms (does not flow), the sample is endotoxin-positive; if the gel collapses, it is negative. For semi-quantitation, test serial dilutions of the sample to estimate endotoxin concentration.

Turbidimetric Method (Quantitative):
1. Mix LAL reagent with the sample (or standard endotoxin) in a microplate/ cuvette.
2. Incubate at 37±1°C, and use a spectrophotometer to monitor turbidity changes (LAL coagulation increases turbidity) over time.
3. Compare the sample’s turbidity curve with standard curves to calculate exact endotoxin concentration.

Chromogenic Method (Quantitative):
1. Mix LAL reagent (with a chromogenic substrate) and the sample. Endotoxin activates LAL enzymes, which cleave the substrate to release a colored product.
2. Incubate, then measure the absorbance of the colored solution at a specific wavelength (e.g., 405 nm).
3. Use the standard curve (built with known endotoxin concentrations) to quantify the sample’s endotoxin level.

Method 2: Recombinant Factor C (rFC) Test
rFC is a genetically engineered protein (mimicking the first step of LAL’s endotoxin reaction), avoiding reliance on horseshoe crabs. Its workflow is similar to the chromogenic LAL method:
1. Mix rFC reagent (with a chromogenic substrate) and the sample.
2. Incubate at 37±1°C; endotoxin binds to rFC, activating the enzyme to cleave the substrate and produce color.
3. Measure absorbance and calculate endotoxin concentration via a standard curve.

3. Result Validation
- Confirm that positive controls show expected reactions (e.g., gel formation, color change) and negative controls show no reaction (to rule out contamination).
- If samples have interfering substances (e.g., detergents, proteins), perform a validation test (e.g., spike recovery: add a known amount of endotoxin to the sample, check if recovery is 50%–200%).
- Only valid results are used to judge if the product meets endotoxin limits (e.g., <0.25 EU/mL for injectables).

Bacterial endotoxin is a lipopolysaccharide (LPS) component in the outer membrane of Gram-negative bacteria. It is released when bacteria die or lyse, and can trigger immune responses (e.g., fever, inflammation) in hosts, even causing severe reactions like septic shock at high levels.

Endotoxin testing is primarily required for the following types of products, as their contact with the human body (especially the bloodstream or sterile tissues) poses risks if contaminated with endotoxins (from gram-negative bacteria):

● Pharmaceuticals: Parenteral drugs (e.g., injectables, infusions, vaccines), ophthalmic preparations, and some nasal sprays (sterile or semi-sterile).

● Medical devices: Devices that contact blood (e.g., catheters, dialysis machines), enter sterile tissues (e.g., surgical implants), or are used in ophthalmic/neural procedures.

● Biologics: Biotherapeutics (e.g., monoclonal antibodies, recombinant proteins), cell and gene therapies, and biological extracts (e.g., plasma derivatives).

● Pharmaceutical excipients & manufacturing materials: Raw materials (e.g., water for injection, buffers, fillers) used in producing above products, to prevent endotoxin introduction during manufacturing.

Pyrogen Test vs. Bacterial Endotoxin Test

Pyrogen tests detect all fever-inducing substances (pyrogens) in pharmaceuticals/medical devices, using live animals (e.g., rabbits) by monitoring body temperature changes. They are broad but slow and raise animal welfare concerns.

Bacterial endotoxin tests (BET), e.g., Limulus Amebocyte Lysate (LAL) assay, specifically target endotoxins (a major pyrogen from Gram-negative bacteria). They are faster, more sensitive, cost-effective, and animal-free, but only detect endotoxins, not other pyrogens. BET is now preferred for most cases, while pyrogen tests are used when BET is unsuitable.

Bacterial endotoxin test (BET) aims to detect or quantify endotoxins (primarily from Gram-negative bacteria) in test samples. Endotoxin-free test tubes are necessary because conventional test tubes may inherently contain endotoxins (e.g., from manufacturing processes, contamination during storage). These exogenous endotoxins would interfere with the test—falsely elevating results, leading to misjudgment of whether the sample itself contains harmful endotoxins. Using endotoxin-free tubes eliminates this interference, ensuring the test’s accuracy and reliability.

The selection of endotoxin-free test tubes becomes necessary in endotoxin detection when the test system (e.g., samples, reagents, diluents) is at risk of being contaminated by endotoxins from ordinary test tubes, which would lead to false-positive results or interfere with the accuracy of detection.

This is particularly critical in scenarios such as:

● Detecting samples with extremely low endotoxin levels (e.g., pharmaceutical-grade water for injection, sterile injectable drugs);

● Using highly sensitive detection methods (e.g., kinetic turbidimetric or chromogenic limulus amebocyte lysate (LAL) assays);

● Preparing reagent dilutions, sample dilutions, or negative controls—where even trace endotoxins from non-endotoxin-free tubes would invalidate the test.

They are not the same—there is a key difference based on the scope of "pyrogens":

● Pyrogens are all substances (endogenous or exogenous) that cause fever, with endotoxins (a type of lipopolysaccharide from Gram-negative bacteria) being the most common exogenous pyrogen.

● Pyrogen-free test tubes: Eliminate all types of pyrogens (including endotoxins and other fever-causing substances).

● Endotoxin-free test tubes: Only target and remove endotoxins (not necessarily other non-endotoxin pyrogens).

In short, endotoxin-free is a subset of pyrogen-free, but pyrogen-free has a broader purification scope.